Healthy Skepticism Library item: 9161

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Wechsler J.
Washington report: better with FTC?
Pharmaceutical Executive 1995 Nov; 15:16, 18, 20

Abstract:

Issues that are raised by the current debate about reforming the U.S. Food and Drug Administration (FDA) regulation of drug advertising and marketing are discussed, including alternatives of modifying the stringent regulation of the FDA or transferring the responsibility to the Federal Trade Commission (FTC). The current role of the FTC, the advantages and disadvantages of adding prescription drug advertising and marketing to the FTC’s responsibilities, which agency will promote pubic health, factors that will influence Congress, and the FDA’s attitude shift to more eagerness in discussing proposals for change are also outlined.